Impact on methemoglobin and certain oxidative stress markers in diabetic and non-diabetic Hansen’s disease patients with dapsone treatment

Ravneet Kaur; Sarabjot Singh Anant; Kuldip Singh

doi:10.51248/.v43i5.3642

Authors

Ravneet Kaur
Sarabjot Singh Anant
Kuldip Singh

DOI:

https://doi.org/10.51248/.v43i5.3642

Keywords:

Hansen’s disease, Mycobacterium leprae, Dapsone, reactive oxygen species (ROS), methemoglobin, malondialdehyde, diabetes, atherosclerosis

Abstract

Introduction: Hansen’s (leprosy) disease is a worldwide healthcare problem, caused by Mycobacterium leprae. Dapsone (a synthetic sulfone), is an antibacterial agent, has both anti-inflammatory and immunomodulatory properties for the treatment of all forms of leprosy. The goal of the study is to evaluate the effect of dapsone on HbA₁C, methemoglobin and certain oxidative stress markers in young patients suffering with Hansen’s disease with and without diabetes.

Methodology: The study was conducted on 70 subjects in age group of 20-45 years. These subjects include 20 healthy subjects (Group 1); 35 non-diabetic Hansen’s patients on dapsone (100mg/day) treatment (Group 2) and 15 diabetic Hansen’s disease on dapsone (100 mg/day) (Group 3). The fasting blood samples were drawn for the evaluation of methemoglobin, HbA₁C, malondialdehyde, reduced glutathione and total antioxidant activity from all the groups.

Results: A significant increase in methemoglobin and malondialdehyde was noted in Group 2 and 3 patients with reference to healthy control subjects (Group 1) while the levels of reduced glutathione, HbA₁C and total antioxidant activity were notably reduced in investigated Group 2 and 3 compared to Group 1. A similar trend of significant increase in methemoglobin and malondialdehyde levels in Group 3 with respect to Group 2 and significant fall in glutathione and total antioxidant activity and nominal fall in HbA₁C was recorded in Group 3 with respect to Group 2.

Conclusion: Aforesaid observations suggested that oxidative stress induced in diabetic and non-diabetic Hansen’s disease patients treated with dapsone due to alteration in Met. Hb, MDA, reduced glutathione and total antioxidant activity levels might be accountable for the etiology of various diseases like cancer, arthritis, and cardiovascular events. A comprehensive study with clinical trials inclusive of complete oxidative stress markers, antioxidant enzymes, pattern of dietary intake with antioxidant vitamin supplements alone and in combination might be beneficial.

Author Biographies

Ravneet Kaur

Department of Dermatology, Guwahati Medical College & Hospital, Guwahati, Assam, India

Sarabjot Singh Anant

Department of Plastic Surgery, Guwahati Medical College & Hospital, Guwahati, Assam, India

Kuldip Singh

Department of Biochemistry, Government of Medical College, Patiala, Punjab, India

References

Harish, S.G., Priyadarshini, D., Kiran, T.S., Shivanand, D.R. Histopathological Evaluation of Hansen’s Disease in The Post Eradication Era at a Tertiary Care Hospital, South India. Int J Cur Res Rev. 2021;13(9): 130-135.

Balakrishnan, S., Karthikeyan, S., Ramu, G. Investigations into the haemolytic effects of dapsone therapy in leprosy patients. Indian J Lepr. 1989; 61(1):10-16.

Queiroz, R.H., Melchior, J.E., Souza, A.M., Gouveia, E., Barbosa, J.C. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT. Pharmaceutica Acta Helvetiae. 1997; 72: 209-213.

Lee, S.M., Geetha, D. Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature. Lee and Geetha Springer Plus. 2015; 4:29-35.

Aquinas, N., Suman, E., Dhanashree, B., Hegde, A. Effect of Cymbopogon citratus on biofilm production by multidrug resistant Acinetobacter baumannii. Biomedicine. 2022 Dec 31;42(6):1243-1248.

Vrutika, H.S., Singh, R.P., Agrawal, S.K., Supekar, B.B., Panindra, L. Health Burden of Hansen's Disease in Central India: A 4-Year Retrospective Study. Indian J Dermatol. 2021; 66(3): 308-313.

Sarawad, S.S., Mendagudli, V.G. Hansen’s disease (Leprosy) - A review. Inter. J. Nursing Edu. & Res. 2021; 9(2): 242-244.

Mendes, A.P.S., Schalcher, T.R., Barros, T.G., Almeida, E.D., Maia, C.S.F., Agrawal, L.M., et al., A Geometric and Electronic Study of Dapsone. J Comput Theor Nanosc. 2011; 8:1428-1431.

Coleman, M.D., Holden, L.J. The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro. Envir. Toxicology and Pharmacol. 2004; 17: 55-59.

Singal, A., Sonthalia, S. Leprosy in post-elimination era in India: Difficult journey ahead. Indian Journal of Dermatology. 2013; 58(6): 443-451.

Rimiolli, L.F., Godoy, M.F. Quantification of the oxidative stress in the blood of people with Hansen's disease undertaking or not a specific treatment. Hansenol Int. 2001; 26: 93-98.

Satoh, K. Serum lipid peroxidation in cerebrovascular disorders determined by new colorimetric method. Clin. Chem. Acta. 1978; 90: 37-43.

Beutler, E., Duron, O., Kelly, B.M. Improved method for the determination of blood glutathione. J. Lab. Clin Med 1963; 61: 882-888.

Benzie, I.F.F., Strain, J.J. Ferric reducing ability of plasma (FRAP) as a measure of antioxidant power- the FRAP assays. Annal Biochem. 1996; 239: 70-76.

Smith, R.S., Alexander, S. Heinz-body Anaemia due to Dapsone. Br Med J. 1959; 7: 625-627.

White, J.C., Beaven, G.H. Fetal haemoglobin. Br Med Bull.1959; 15: 33-39.

Coleman, M.D., Coleman, N.A. Drug-Induced Met-hemoglobinemia. Drug Safet. 1996; 14: 394-405.

Ward, E., McCarthy, M.W. Dapsone-Induced Methemoglobinemia Kristina The Annals of Pharmacotherapy.1998; 32: 549-556

Ghorui, A.K., Patra, P.K. Dapsone induced hemolysis in a patient with Hansen’s disease and G6PD deficiency: A preventable peril. Clin Case Rep. 2022;10:e05700.

Lee, S.M., Geetha, D. Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature. SpringerPlus. 2015; 4: 29-35.

Dalpino, D., Diltor, L.A.M., Opromolla, V.A. Atividade da NADH-redutase de metemoglobinaemhemolisado e membranaseritrocita´rias de pacienteshansenianos sob tratamentosulfoˆnico. Hansen Int 1998; 23:14-26.

Bassey, I.E., Inyang, I.E., Akpan, U.O., Isong, I.K.P., Icha, B.E., Ayawan, V.M., et al., Cardiovascular disease risk factors and markers of oxidative stress and DNA damage in leprosy patients in Southern Nigeria. Nigeria. PLoS Negl Trop Dis. 2020;14(10): e0008749.

Singh, K., Ahluwalia, P. Effect of monosodium glutamate on lipid peroxidation and certain antioxidant enzymes in cardiac tissue of alcoholic adult male mice. J Cardiovasc. Dis. Res. 2012; 3: 12-18.

Kuldip, S., Singh, G. Impact of microalbuminuria on certain antioxidant enzymes in diabetic patients. Biomedicine. 2016; 36(3):74-78.

Silva, R.V.G., Arau, J.O., Aarao, T.L.S., Silva, C.P.D., Sousa, J.R., Quaresma, J.A.S. et al., Correlation between therapy and lipid profile of leprosy patients: is there a higher risk for developing cardiovascular diseases after treatment? Infect Dis Poverty. 2017; 6(1):82.

Chhabra, N., Bhattacharya, S.N., Singal, A., Ahmed, R.S., Verma, P. Profile of oxidative stress in response to treatment for Type 1 leprosy reaction. Lepr Rev. 2015; 86(1): 80-88.

Osadolor, H.B., Okosun, R. Non-enzymatic antioxidants status of leprosy patients in a leprosarium settlement in Nigeria. Biochem. 2014; 26(2): 50-54.

Trimbake, S.B., Sontakke, A.N., Dhat, V.V. Oxidative stress and antioxidant vitamins in leprosy. Int J Res Med Sci. 2013; 1(3): 100-104.

Kurutas, E.B. The importance of antioxidants which play the role in cellular response against oxidative/ nitrosative stress: current state. Nutr J. 2016; 15(1):71-77.